AZTA
Azenta, Inc.
Price Chart
Latest Quote
$23.13
| Previous Close | $22.95 |
| Open | $22.93 |
| Day High | $23.40 |
| Day Low | $22.82 |
| Volume | 597,601 |
Stock Information
| Shares Outstanding | 46.09M |
| Total Debt | $55.71M |
| Cash Equivalents | $380.52M |
| Revenue | $596.48M |
| Net Income | $-110.89M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $1.05B |
| EPS (TTM) | $-2.41 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $741.32M |
| Sales | $596.48M |
| Income | $-110.89M |
| Book/sh | $33.73 |
| Cash/sh | $8.26 |
| Employees | 3K |
Financial Ratios
| Quick Ratio | 2.12 |
| Current Ratio | 2.83 |
| Debt/Eq | 3.58 |
Returns & Margins
| ROA | -0.64% |
| ROE | -6.81% |
| Gross Margin | 44.33% |
| Operating Margin | -10.56% |
| Profit Margin | -29.06% |
Ownership
| Insider Ownership | 1.00% |
| Institutional Ownership | 120.43% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 36.93 |
| PEG | 0.53 |
| P/S | 1.75 |
| P/B | 0.67 |
Analyst Data
| Recommendation | buy |
| Target Price | $26.20 |
Technical Indicators
| SMA20 | $22.16 |
| SMA50 | $22.17 |
| SMA200 | $28.69 |
| RSI | 52.22 |
| ATR | 0.9657 |
| Shares Float | 40.60M |
| Short Float | 20.04% |
| Short Ratio | 3.72 |
| Volatility | 1.40 |
| Rel Volume | 0.56 |
Performance History
| Week | +1.32% |
| Month | +39.62% |
| Quarter | +5.12% |
| 6 Months | -35.36% |
| YTD | -32.09% |
| Year | -26.12% |
| 3 Years | -51.17% |
| 5 Years | -76.95% |
| 10 Years | +108.49% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $22.67 | 607,287 |
| 2026-06-16 | $23.13 | 640,300 |
| 2026-06-15 | $22.95 | 739,100 |
| 2026-06-12 | $22.59 | 585,100 |
| 2026-06-11 | $22.46 | 1,042,000 |
| 2026-06-10 | $22.38 | 1,053,800 |
| 2026-06-09 | $22.72 | 1,000,400 |
| 2026-06-08 | $22.71 | 832,100 |
| 2026-06-05 | $22.69 | 1,090,900 |
| 2026-06-04 | $22.84 | 1,395,800 |
| 2026-06-03 | $23.89 | 1,042,600 |
| 2026-06-02 | $23.43 | 1,044,200 |
| 2026-06-01 | $23.19 | 1,146,800 |
| 2026-05-29 | $22.88 | 1,427,400 |
| 2026-05-28 | $22.49 | 1,854,200 |
| 2026-05-27 | $21.34 | 1,057,600 |
| 2026-05-26 | $20.50 | 957,100 |
| 2026-05-22 | $20.18 | 1,087,800 |
| 2026-05-21 | $19.54 | 1,394,100 |
| 2026-05-20 | $18.57 | 1,678,800 |
| 2026-05-19 | $17.65 | 1,795,200 |
| 2026-05-18 | $16.24 | 2,277,300 |
About Azenta, Inc.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
đ° Latest News
3 Cash-Heavy Stocks We Keep Off Our Radar
StockStory âĸ 2026-06-16T09:16:07Z3 Hyped Up Stocks We Find Risky
StockStory âĸ 2026-06-11T09:29:37Z3 Small-Cap Stocks with Open Questions
StockStory âĸ 2026-06-10T09:05:28Z3 High-Flying Stocks Walking a Fine Line
StockStory âĸ 2026-06-08T13:01:50Z3 Undervalued Small Caps With Notable Insider Buying Activity
Simply Wall St. âĸ 2026-05-28T11:39:52ZWinners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
StockStory âĸ 2026-05-21T23:48:55Z1 Russell 2000 Stock Worth Your Attention and 2 We Question
StockStory âĸ 2026-05-17T05:40:55ZAzentaâs Q1 Earnings Call: Our Top 5 Analyst Questions
StockStory âĸ 2026-05-16T23:16:55ZAzenta, Inc. Q2 2026 Earnings Call Summary
Moby âĸ 2026-05-06T20:48:44ZAzenta Q2 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T14:55:06ZIncome Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $323,541,000 | $318,826,000 | $312,276,000 | $299,914,000 |
| Cost Of Revenue | $323,541,000 | $318,826,000 | $312,276,000 | $299,914,000 |
| Total Revenue | $593,821,000 | $573,448,000 | $551,486,000 | $555,498,000 |
| Operating Revenue | $593,821,000 | $573,448,000 | $551,486,000 | $555,498,000 |
| Expenses | ||||
| Total Expenses | $615,494,000 | $613,308,000 | $608,155,000 | $578,921,000 |
| Other Income Expense | $-4,249,000 | $-12,156,000 | $-6,877,000 | $-2,210,000 |
| Other Non Operating Income Expenses | $922,000 | $-732,000 | $-2,300,000 | $-898,000 |
| Net Non Operating Interest Income Expense | $18,779,000 | $32,891,000 | $43,541,000 | $15,697,000 |
| Operating Expense | $291,953,000 | $294,482,000 | $295,879,000 | $279,007,000 |
| Interest Expense | - | - | $0 | $4,589,000 |
| Interest Expense Non Operating | - | - | $0 | $4,589,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $24,458,000 | $-24,366,000 | $-8,040,000 | $-11,286,000 |
| Net Interest Income | $18,779,000 | $32,891,000 | $43,541,000 | $15,697,000 |
| Interest Income | $18,779,000 | $32,891,000 | $43,541,000 | $15,697,000 |
| Normalized Income | $28,543,090 | $-15,341,040 | $-4,424,170 | $-10,249,520 |
| Net Income From Continuing And Discontinued Operation | $-55,763,000 | $-164,897,000 | $-14,636,000 | $2,132,859,000 |
| Total Operating Income As Reported | $-26,844,000 | $-51,284,000 | $-61,246,000 | $-24,735,000 |
| Net Income Common Stockholders | $-55,763,000 | $-164,897,000 | $-14,636,000 | $2,132,859,000 |
| Net Income | $-55,763,000 | $-164,897,000 | $-14,636,000 | $2,132,859,000 |
| Net Income Including Noncontrolling Interests | $-55,763,000 | $-164,897,000 | $-14,636,000 | $2,132,859,000 |
| Net Income Discontinuous Operations | $-80,221,000 | $-140,531,000 | $-6,596,000 | $2,144,145,000 |
| Net Income Continuous Operations | $24,458,000 | $-24,366,000 | $-8,040,000 | $-11,286,000 |
| Pretax Income | $-7,143,000 | $-19,125,000 | $-20,005,000 | $-9,936,000 |
| Special Income Charges | $-5,171,000 | $-11,424,000 | $-4,577,000 | $-1,312,000 |
| Interest Income Non Operating | $18,779,000 | $32,891,000 | $43,541,000 | $15,697,000 |
| Operating Income | $-21,673,000 | $-39,860,000 | $-56,669,000 | $-23,423,000 |
| Gross Profit | $270,280,000 | $254,622,000 | $239,210,000 | $255,584,000 |
| Per Share | ||||
| Diluted EPS | $-1.30 | $-3.60 | $-0.22 | $28.48 |
| Basic EPS | $-1.30 | $-3.60 | $-0.22 | $28.48 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,085,910 | $-2,399,040 | $-961,170 | $-275,520 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $44,707,000 | $62,308,000 | $33,492,000 | $31,591,000 |
| Total Unusual Items | $-5,171,000 | $-11,424,000 | $-4,577,000 | $-1,312,000 |
| Total Unusual Items Excluding Goodwill | $-5,171,000 | $-11,424,000 | $-4,577,000 | $-1,312,000 |
| Reconciled Depreciation | $61,209,000 | $90,744,000 | $85,584,000 | $53,702,000 |
| EBITDA (Bullshit earnings) | $39,536,000 | $50,884,000 | $28,915,000 | $30,279,000 |
| EBIT | $-21,673,000 | $-39,860,000 | $-56,669,000 | $-23,423,000 |
| Diluted Average Shares | $45,896,000 | $45,570,084 | $66,253,000 | $74,897,000 |
| Basic Average Shares | $45,743,000 | $45,570,084 | $66,253,000 | $74,897,000 |
| Diluted NI Availto Com Stockholders | $-55,763,000 | $-164,897,000 | $-14,636,000 | $2,132,859,000 |
| Tax Provision | $-31,601,000 | $5,241,000 | $-11,965,000 | $1,350,000 |
| Impairment Of Capital Assets | $0 | $4,658,000 | $0 | $0 |
| Restructuring And Mergern Acquisition | $5,171,000 | $6,766,000 | $4,577,000 | $1,312,000 |
| Research And Development | $30,390,000 | $31,524,000 | $32,141,000 | $27,542,000 |
| Selling General And Administration | $261,563,000 | $262,958,000 | $263,738,000 | $251,465,000 |
| Other Special Charges | - | - | - | $632,000 |
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $922,777,000 | $951,396,000 | $1,455,860,000 | $2,671,362,000 |
| Total Assets | $2,059,582,000 | $2,100,265,000 | $2,885,720,000 | $3,716,122,000 |
| Total Non Current Assets | $1,351,243,000 | $1,267,234,000 | $1,466,764,000 | $1,256,776,000 |
| Other Non Current Assets | $91,121,000 | $184,464,000 | $3,891,000 | $57,093,000 |
| Non Current Deferred Assets | $726,000 | $837,000 | $571,000 | $1,169,000 |
| Non Current Deferred Taxes Assets | $726,000 | $837,000 | $571,000 | $1,169,000 |
| Non Current Accounts Receivable | $45,600,000 | - | - | - |
| Investmentin Financial Assets | $201,585,000 | $49,454,000 | $111,338,000 | $352,020,000 |
| Goodwill And Other Intangible Assets | $804,209,000 | $816,451,000 | $1,078,640,000 | $692,024,000 |
| Other Intangible Assets | $101,814,000 | $125,042,000 | $294,301,000 | $178,401,000 |
| Current Assets | $708,339,000 | $833,031,000 | $1,418,956,000 | $2,459,346,000 |
| Other Current Assets | $64,660,000 | $51,360,000 | $98,754,000 | $132,621,000 |
| Assets Held For Sale Current | $73,535,000 | $99,052,000 | - | $0 |
| Restricted Cash | $2,359,000 | $2,069,000 | $4,650,000 | $382,596,000 |
| Inventory | $74,956,000 | $71,320,000 | $128,198,000 | $85,544,000 |
| Receivables | $151,909,000 | $178,038,000 | $156,535,000 | $163,758,000 |
| Taxes Receivable | $9,728,000 | $23,866,000 | - | - |
| Accounts Receivable | $142,181,000 | $154,172,000 | $156,535,000 | $163,758,000 |
| Allowance For Doubtful Accounts Receivable | $-4,649,000 | $-5,349,000 | $-8,057,000 | $-5,162,000 |
| Gross Accounts Receivable | $146,830,000 | $159,521,000 | $164,592,000 | $168,920,000 |
| Cash Cash Equivalents And Short Term Investments | $340,920,000 | $431,192,000 | $1,017,783,000 | $1,570,038,000 |
| Cash And Cash Equivalents | $279,783,000 | $280,030,000 | $678,910,000 | $658,274,000 |
| Hedging Assets Current | - | $0 | $13,036,000 | $124,789,000 |
| Prepaid Assets | - | - | - | $132,621,000 |
| Debt | ||||
| Total Debt | $51,244,000 | $56,677,000 | $60,436,000 | $49,227,000 |
| Long Term Debt And Capital Lease Obligation | $51,244,000 | $56,677,000 | $60,436,000 | $49,227,000 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $332,596,000 | $332,418,000 | $351,220,000 | $352,736,000 |
| Total Non Current Liabilities Net Minority Interest | $94,922,000 | $126,329,000 | $140,292,000 | $122,190,000 |
| Other Non Current Liabilities | $11,142,000 | $9,272,000 | $12,175,000 | $6,724,000 |
| Liabilities Heldfor Sale Non Current | $14,291,000 | $42,196,000 | - | $0 |
| Non Current Deferred Liabilities | $18,245,000 | $18,184,000 | $67,681,000 | $66,239,000 |
| Non Current Deferred Taxes Liabilities | $18,245,000 | $18,184,000 | $67,681,000 | $66,239,000 |
| Current Liabilities | $237,674,000 | $206,089,000 | $210,928,000 | $230,546,000 |
| Other Current Liabilities | $61,688,000 | $31,965,000 | - | - |
| Current Deferred Liabilities | $58,068,000 | $52,817,000 | $52,321,000 | $53,195,000 |
| Payables And Accrued Expenses | $82,119,000 | $92,091,000 | $124,696,000 | $135,453,000 |
| Payables | $47,138,000 | $42,429,000 | $63,769,000 | $83,491,000 |
| Total Tax Payable | $9,416,000 | $9,085,000 | $27,973,000 | $44,837,000 |
| Income Tax Payable | $9,416,000 | $9,085,000 | $7,378,000 | $28,419,000 |
| Accounts Payable | $37,722,000 | $33,344,000 | $35,796,000 | $38,654,000 |
| Equity | ||||
| Common Stock Equity | $1,726,986,000 | $1,767,847,000 | $2,534,500,000 | $3,363,386,000 |
| Total Equity Gross Minority Interest | $1,726,986,000 | $1,767,847,000 | $2,534,500,000 | $3,363,386,000 |
| Stockholders Equity | $1,726,986,000 | $1,767,847,000 | $2,534,500,000 | $3,363,386,000 |
| Gains Losses Not Affecting Retained Earnings | $-22,213,000 | $-13,464,000 | $-62,426,000 | $-83,916,000 |
| Other Equity Adjustments | $-22,213,000 | $-13,464,000 | $-62,426,000 | $-83,916,000 |
| Retained Earnings | $1,419,956,000 | $1,475,719,000 | $1,641,009,000 | $1,655,356,000 |
| Other | ||||
| Treasury Shares Number | $13,461,869 | $13,461,869 | $13,461,869 | $13,461,869 |
| Ordinary Shares Number | $45,858,979 | $45,570,084 | $57,832,378 | $75,020,256 |
| Share Issued | $59,320,848 | $59,031,953 | $71,294,247 | $88,482,125 |
| Tangible Book Value | $922,777,000 | $951,396,000 | $1,455,860,000 | $2,671,362,000 |
| Invested Capital | $1,726,986,000 | $1,767,847,000 | $2,534,500,000 | $3,363,386,000 |
| Working Capital | $470,665,000 | $626,942,000 | $1,208,028,000 | $2,228,800,000 |
| Capital Lease Obligations | $51,244,000 | $56,677,000 | $60,436,000 | $49,227,000 |
| Total Capitalization | $1,726,986,000 | $1,767,847,000 | $2,534,500,000 | $3,363,386,000 |
| Treasury Stock | $200,956,000 | $200,956,000 | $200,956,000 | $200,956,000 |
| Additional Paid In Capital | $529,605,000 | $505,958,000 | $1,156,160,000 | $1,992,017,000 |
| Capital Stock | $594,000 | $590,000 | $713,000 | $885,000 |
| Common Stock | $594,000 | $590,000 | $713,000 | $885,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $51,244,000 | $56,677,000 | $60,436,000 | $49,227,000 |
| Current Deferred Revenue | $58,068,000 | $52,817,000 | $52,321,000 | $53,195,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $35,799,000 | $29,216,000 | $33,911,000 | $41,898,000 |
| Current Accrued Expenses | $34,981,000 | $49,662,000 | $60,927,000 | $51,962,000 |
| Investments And Advances | $201,585,000 | $49,454,000 | $111,338,000 | $352,020,000 |
| Available For Sale Securities | $201,585,000 | $49,454,000 | $111,338,000 | $352,020,000 |
| Goodwill | $702,395,000 | $691,409,000 | $784,339,000 | $513,623,000 |
| Net PPE | $208,002,000 | $216,028,000 | $272,324,000 | $154,470,000 |
| Accumulated Depreciation | $-166,009,000 | $-142,124,000 | $-114,876,000 | $-84,046,000 |
| Gross PPE | $374,011,000 | $358,152,000 | $387,200,000 | $238,516,000 |
| Leases | $61,242,000 | $59,951,000 | $52,670,000 | $37,495,000 |
| Construction In Progress | $22,388,000 | $29,554,000 | $33,915,000 | $36,644,000 |
| Other Properties | $54,048,000 | $64,976,000 | $71,298,000 | $2,476,000 |
| Machinery Furniture Equipment | $202,343,000 | $170,764,000 | $187,447,000 | $132,320,000 |
| Buildings And Improvements | $33,990,000 | $32,907,000 | $41,870,000 | $29,581,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $36,587,000 | $36,120,000 | $56,937,000 | $41,043,000 |
| Work In Process | $5,050,000 | $7,739,000 | $11,400,000 | $4,816,000 |
| Raw Materials | $33,319,000 | $27,461,000 | $59,861,000 | $39,685,000 |
| Other Short Term Investments | $61,137,000 | $151,162,000 | $338,873,000 | $911,764,000 |
| Employee Benefits | - | - | - | $261,000 |
| Non Current Pension And Other Postretirement Benefit Plans | - | - | - | $261,000 |
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $38,324,000 | $12,351,000 | $-33,602,000 | $-543,481,000 |
| Operating Activities | ||||
| Operating Cash Flow | $72,181,000 | $49,743,000 | $5,834,000 | $-466,046,000 |
| Cash Flow From Continuing Operating Activities | $72,181,000 | $49,743,000 | $5,834,000 | $-466,046,000 |
| Operating Gains Losses | $93,829,000 | $296,000 | $43,000 | $-2,129,654,000 |
| Investing Activities | ||||
| Capital Expenditure | $-33,857,000 | $-37,392,000 | $-39,436,000 | $-77,435,000 |
| Investing Cash Flow | $-90,461,000 | $224,739,000 | $431,384,000 | $1,465,590,000 |
| Cash Flow From Continuing Investing Activities | $-90,461,000 | $224,739,000 | $431,384,000 | $1,465,590,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-661,703,000 | $-838,514,000 | $0 |
| Issuance Of Capital Stock | $2,770,000 | $3,279,000 | $3,621,000 | $5,245,000 |
| Financing Cash Flow | $-9,591,000 | $-659,207,000 | $-840,459,000 | $-62,762,000 |
| Cash Flow From Continuing Financing Activities | $-9,591,000 | $-659,207,000 | $-840,459,000 | $-62,762,000 |
| Net Other Financing Charges | $-11,376,000 | - | $-4,988,000 | $-10,400,000 |
| Net Common Stock Issuance | $2,770,000 | $-658,424,000 | $-834,893,000 | $5,245,000 |
| Common Stock Issuance | $2,770,000 | $3,279,000 | $3,621,000 | $5,245,000 |
| Cash Dividends Paid | - | $0 | $0 | $-7,494,000 |
| Common Stock Dividend Paid | - | $0 | $0 | $-7,494,000 |
| Other | ||||
| Repayment Of Debt | $-985,000 | $-783,000 | $-578,000 | $-50,113,000 |
| Income Tax Paid Supplemental Data | $6,568,000 | $2,704,000 | $43,073,000 | $452,461,000 |
| End Cash Position | $296,685,000 | $320,990,000 | $684,045,000 | $1,041,296,000 |
| Beginning Cash Position | $320,990,000 | $684,045,000 | $1,041,296,000 | $285,333,000 |
| Effect Of Exchange Rate Changes | $3,566,000 | $21,670,000 | $45,990,000 | $-180,819,000 |
| Changes In Cash | $-27,871,000 | $-384,725,000 | $-403,241,000 | $936,782,000 |
| Common Stock Payments | $0 | $-661,703,000 | $-838,514,000 | $0 |
| Net Issuance Payments Of Debt | $-985,000 | $-783,000 | $-578,000 | $-50,113,000 |
| Net Long Term Debt Issuance | $-985,000 | $-783,000 | $-578,000 | $-50,113,000 |
| Long Term Debt Payments | $-985,000 | $-783,000 | $-578,000 | $-50,113,000 |
| Net Investment Purchase And Sale | $-56,604,000 | $262,131,000 | $857,328,000 | $-1,270,215,000 |
| Sale Of Investment | $394,805,000 | $667,706,000 | $1,093,522,000 | $705,384,000 |
| Purchase Of Investment | $-451,409,000 | $-405,575,000 | $-236,194,000 | $-1,975,599,000 |
| Net Business Purchase And Sale | $0 | $0 | $-386,508,000 | $2,813,240,000 |
| Purchase Of Business | $0 | $0 | $-386,508,000 | $-125,876,000 |
| Net PPE Purchase And Sale | $-33,857,000 | $-37,392,000 | $-39,436,000 | $-73,435,000 |
| Purchase Of PPE | $-33,857,000 | $-37,392,000 | $-39,436,000 | $-73,435,000 |
| Change In Working Capital | $-22,837,000 | $3,039,000 | $-29,038,000 | $-72,733,000 |
| Change In Other Working Capital | $-3,634,000 | $-6,548,000 | $-42,542,000 | $17,512,000 |
| Change In Payables And Accrued Expense | $8,029,000 | $5,758,000 | $-29,205,000 | $7,781,000 |
| Change In Accrued Expense | $6,992,000 | $-3,438,000 | $-14,495,000 | $11,707,000 |
| Change In Payable | $1,037,000 | $9,196,000 | $-14,710,000 | $-3,926,000 |
| Change In Account Payable | $1,037,000 | $9,196,000 | $-14,710,000 | $-3,926,000 |
| Change In Inventory | $-2,671,000 | $15,896,000 | $8,253,000 | $-66,629,000 |
| Change In Receivables | $-24,561,000 | $-12,067,000 | $34,456,000 | $-31,397,000 |
| Changes In Account Receivables | $21,039,000 | $-12,067,000 | $34,456,000 | $-31,397,000 |
| Stock Based Compensation | $20,881,000 | $14,467,000 | $9,376,000 | $10,666,000 |
| Asset Impairment Charge | $3,478,000 | $123,695,000 | $0 | $0 |
| Amortization Of Securities | $-1,578,000 | $-6,032,000 | $-7,870,000 | $-1,894,000 |
| Deferred Tax | $-27,038,000 | $-15,886,000 | $-28,740,000 | $24,469,000 |
| Deferred Income Tax | $-27,038,000 | $-15,886,000 | $-28,740,000 | $24,469,000 |
| Depreciation Amortization Depletion | $61,209,000 | $90,744,000 | $85,584,000 | $53,702,000 |
| Depreciation And Amortization | $61,209,000 | $90,744,000 | $85,584,000 | $53,702,000 |
| Gain Loss On Sale Of PPE | $711,000 | $296,000 | $43,000 | $-21,000 |
| Net Income From Continuing Operations | $-55,763,000 | $-164,897,000 | $-14,636,000 | $2,132,859,000 |
| Interest Paid Supplemental Data | - | $0 | $0 | $469,000 |
| Sale Of Business | - | $0 | $0 | $2,939,116,000 |
| Net Intangibles Purchase And Sale | - | $0 | $0 | $-4,000,000 |
| Purchase Of Intangibles | - | $0 | $0 | $-4,000,000 |
| Taxes Refund Paid | - | $0 | $0 | $-431,600,000 |
| Other Non Cash Items | - | $4,317,000 | $-8,885,000 | $-51,861,000 |
| Gain Loss On Sale Of Business | - | $0 | $0 | $-2,130,265,000 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Change In Prepaid Assets | - | - | - | - |
| Earnings Losses From Equity Investments | - | - | - | - |